Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Back
  4. Musculoskeletal and Joint Disease
  5. Oral Bisphosphonates, Longer Term Treatment for Osteoporosis (249)
Update your RDS mobile app to v4.7.2 to download toolkits even when website is down.

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. You will see that each toolkit has a small QR code icon in the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively update to the latest release - RDS app version 4.7.1 - to see this improvement.

Updating to this latest version of the RDS app is also strongly recommended to get the full benefits of the new resilience  arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.  To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Oral Bisphosphonates, Longer Term Treatment for Osteoporosis (249)

Warning

N.B. This guideline does not apply to patients age 75 or above with a hip fracture. There is separate guidance for secondary fracture prevention after hip fracture for women 75 years or over available on NHSGGC Clinical Guideline Platform (here).

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 15/01/2025

Next review date: 30/11/2027

Author(s): Maria Talla.

Version: 4

Author email(s): maria.talla@nhs.scot.

Approved By: Medicines Utilisation Subcommittee of ADTC

Reviewer name(s): Maria Talla.

Document Id: 249